Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase

Arthritis and Rheumatism

Volumn 41, Issue 7, 1998, Pages 1275-1286

  Pelletier, Jean Pierre ^a   Jovanovic, Dragan ^a   Fernandes, Julio C ^a   Manning, Pamela ^b   Connor, Jane R ^b   Currie, Mark G ^b   Di Battista, John A ^a   Martel Pelletier, Johanne ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; METALLOPROTEINASE; N IMINOETHYLLYSINE; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYNOVIAL FLUID LEVEL;

EID: 0031864605     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T     Document Type: Article

References (42)

1. Pelletier JP, Martel-Pelletier J, Howell DS. Etiopathogenesis of osteoarthritis. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 1969-84.
2. Pelletier JP, Di Battista JA, Roughley PJ, McCollum R, Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993;19:545-68.
3. Dean DD. Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum 1991;20:2-11.
4. Doré S, Pelletier J-P, Di Battista JA, Tardif G, Brazeau P, Martel-Pelletier J. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation: possible role of IGF-1-binding proteins. Arthritis Rheum 1994;37:253-63.
5. Hickery MS, Palmer RMJ, Charles IG, Moncada S, Bayliss MT. The role of nitric oxide in IL-1 and TNFα-induced inhibition of proteoglycan synthesis in human articular cartilage [abstract]. Trans Orthop Res Soc 1994;19:77.
6. Taskiran D, Stefanovic-Racic M, Georgescu HI, Evans CH. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-8.
7. Järvinen TAH, Moilanen T, Järvinen TLN, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators Inflamm 1995;4: 107-11.
8. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-20.
9. Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993;193:398-405.
10. Maier R, Bilbe G, Rediske J, Lotz M. Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression [abstract]. Biochim Biophys Acta 1994;145:1208.
11. Charles IG, Palmer RM, Hickery MS, Bayliss MT, Chubb AP, Hall VS, et al. Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci U S A 1993;90:11419-23.
12. Amin AR, Di Cesare PE, Vyas P, Attur MG, Tzeng E, Billiar TR, et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for an inducible "neuronal-like" nitric oxide synthase. J Exp Med 1995;182: 2097-102.
13. Pelletier J-P, Mineau F, Ranger P, Tardif G, Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996;4:77-84.
14. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
15. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996;184:1519-24.
16. Sakurai H, Kohsaka H, Liu M, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
17. Cannon GW, Openshaw SJ, Hibbs JB Jr, Hoidal JR, Huecksteadt TP, Griffiths MM. Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 1996;39: 1677-84.
18. Evans CH, Stefanovic-Racic M, Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin Orthop 1995;312:275-94.
19. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 1993;36:1036-44.
20. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
21. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, et al. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 1995;273:15-24.
22. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994;37:1062-9.
23. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 1995;22:1922-8.
24. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q, Nathan DF, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
25. 6-(1-iminoethyl) lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 1994;37:3886-8.
26. Pelletier J-P, Di Battista JA, Raynauld J-P, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995;72:578-86.
27. Pelletier J-P, Mineau F, Raynauld J-P, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994;37:414-23.
28. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, et al. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis. Arthritis Rheum 1995;38:1290-303.
29. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
30. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-37.
31. Pelletier J-P, Martel-Pelletier J, Ghandur-Mnaymneh L, Howell DS, Woessner JF Jr. Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1985;28:554-61.
32. 14C] acetylated collagen. Anal Biochem 1979; 99:340-5.
33. Chavira R Jr, Burnett TJ, Hageman JH. Assaying proteinases with azocoll. Anal Biochem 1984;136:446-50.
34. Brandt KD. Insights into the natural history of osteoarthritis provided by the cruciate-deficient dog: an animal model of osteoarthritis. Ann N Y Acad Sci 1994;732:199-205.
35. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 1996;39: 1535-44.
36. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-90.
37. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
38. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Phsyiol 1996;271: C1424-37.
39. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995;96:301-8.
40. Salvemini D, Wang Z-Q, Wyatt PS, Bourdon DM, Marino MH, Manning PT, et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996;118:829-38.
41. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritic-affected cartilage. J Clin Invest 1997;99:1231-7.
42. Di Battista JA, Martel-Pelletier J, Fujimoto N, Obata K, Zafarullah M, Pelletier JP. Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts: mediation by cyclic-AMP signalling pathway. Lab Invest 1994;70: 807-15.